Valneva to present at upcoming td cowen and van lanschot kempen healthcare investor conferences

Saint-herblain (france), march 4, 2024 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that its senior management will participate at upcoming investor conferences in the united states and europe. ceo thomas lingelbach will present valneva at the td cowen 44th annual health care conference, taking place march 4 - 6, 2024, in boston, ma. mr. lingelbach and cfo peter bÜhler will also meet with institutional investors during the van lanschot kempen life sciences conference, held april 16 - 17, 2024, in amsterdam, the netherlands.
VALN Ratings Summary
VALN Quant Ranking